Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex-Reference-Cited by-同舟云学术

Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex

Published:2015-07 Issue:7 Volume:2 Page:730-743
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Kolumam Ganesh,Chen Mark Z.,Tong Raymond,Zavala-Solorio Jose,Kates Lance,van Bruggen Nicholas,Ross Jed,Wyatt Shelby K.,Gandham Vineela D.,Carano Richard A.D.,Dunshee Diana Ronai,Wu Ai-Luen,Haley Benjamin,Anderson Keith,Warming Søren,Rairdan Xin Y.,Lewin-Koh Nicholas,Zhang Yingnan,Gutierrez Johnny,Baruch Amos,Gelzleichter Thomas R.,Stevens Dale,Rajan Sharmila,Bainbridge Travis W.,Vernes Jean-Michel,Meng Y. Gloria,Ziai James,Soriano Robert H.,Brauer Matthew J.,Chen Yongmei,Stawicki Scott,Kim Hok Seon,Comps-Agrar Laëtitia,Luis Elizabeth,Spiess Christoph,Wu Yan,Ernst James A.,McGuinness Owen P.,Peterson Andrew S.,Sonoda Junichiro

Funder

Genentech

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference57 articles.

1. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue;Adams;Mol. Metab.,2012

2. Considerations in the design of hyperinsulinemic–euglycemic clamps in the conscious mouse;Ayala;Diabetes,2006

3. FGF21 regulates metabolism and circadian behavior by acting on the nervous system;Bookout;Nat. Med.,2013

4. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes;Bordicchia;J. Clin. Invest.,2012

5. Brown adipose tissue: function and physiological significance;Cannon;Physiol. Rev.,2004

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B;Antiviral Research;2024-09

2. The role of FGF19 in metabolic regulation: insights from preclinical models to clinical trials;American Journal of Physiology-Endocrinology and Metabolism;2024-09-01

3. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?;Pharmacology & Therapeutics;2024-07

4. Double promoter and tandem gene strategy for efficiently expressing recombinant FGF21;Microbial Cell Factories;2024-06-12

5. Current status and future perspectives of FGF21 analogues in clinical trials;Trends in Endocrinology & Metabolism;2024-05